Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.10 USD
Change Today -0.54 / -4.67%
Volume 13.2K
TCON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 1:52 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles P. Theuer M.D., Ph.D.

Chief Executive Officer, President and Director, TRACON Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
51$1,233,571
As of Fiscal Year 2014

Background*

Dr. Charles P. Theuer, M.D., Ph.D., has been the President and Chief Executive Officer of Tracon Pharmaceuticals, Inc. Since July 2006. Dr. Theuer served as Vice President of Clinical Research and Chief Medical Officer of TargeGen Inc. from October 2004 to 2006, where he led the development of small molecule kinase inhibitors in oncology, ophthalmology and cardiovascular disease. Dr. Theuer joined TargeGen from Pfizer where he led the clinical development of Sutent® ...

Read Full Background

Corporate Headquarters*

8910 University Center Lane
San Diego, California 92122

United States

Phone: 858-550-0780
Fax: 858-550-0786

Board Members Memberships*

2006-Present
Chief Executive Officer, President and Director

Education*

BS
Massachusetts Institute of Technology
MD
University of California-San Francisco
PhD
University of California, Irvine

Other Affiliations*

Annual Compensation*

Salary$395,000
Total Annual Compensation$395,000

Stock Options*

All Other Compensation$10,400
Exercisable Options218,162
Unexercisable Options196,985
Total Number of Options415,147

Total Compensation*

Total Annual Cash Compensation$596,975
Total Short Term Compensation$395,000
Other Long Term Compensation$10,400
Total Calculated Compensation$1,233,571
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TCON:US $11.10 USD -0.54

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRACON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.